AU2007325465B2 - Assay membrane and method of use thereof - Google Patents

Assay membrane and method of use thereof Download PDF

Info

Publication number
AU2007325465B2
AU2007325465B2 AU2007325465A AU2007325465A AU2007325465B2 AU 2007325465 B2 AU2007325465 B2 AU 2007325465B2 AU 2007325465 A AU2007325465 A AU 2007325465A AU 2007325465 A AU2007325465 A AU 2007325465A AU 2007325465 B2 AU2007325465 B2 AU 2007325465B2
Authority
AU
Australia
Prior art keywords
antibody
membrane
control
protein
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007325465A
Other languages
English (en)
Other versions
AU2007325465A1 (en
Inventor
Sarita Kumble
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pictor Ltd
Original Assignee
Pictor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pictor Ltd filed Critical Pictor Ltd
Publication of AU2007325465A1 publication Critical patent/AU2007325465A1/en
Application granted granted Critical
Publication of AU2007325465B2 publication Critical patent/AU2007325465B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5025—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures for parallel transport of multiple samples
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50855—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates using modular assemblies of strips or of individual wells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Clinical Laboratory Science (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
AU2007325465A 2006-11-28 2007-10-26 Assay membrane and method of use thereof Ceased AU2007325465B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86177106P 2006-11-28 2006-11-28
US60/861,771 2006-11-28
PCT/US2007/082732 WO2008067091A2 (en) 2006-11-28 2007-10-26 Assay membrane and method of use thereof

Publications (2)

Publication Number Publication Date
AU2007325465A1 AU2007325465A1 (en) 2008-06-05
AU2007325465B2 true AU2007325465B2 (en) 2013-09-05

Family

ID=39468589

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007325465A Ceased AU2007325465B2 (en) 2006-11-28 2007-10-26 Assay membrane and method of use thereof

Country Status (9)

Country Link
US (2) US9625453B2 (cg-RX-API-DMAC7.html)
EP (1) EP2092333B1 (cg-RX-API-DMAC7.html)
JP (1) JP5240945B2 (cg-RX-API-DMAC7.html)
AU (1) AU2007325465B2 (cg-RX-API-DMAC7.html)
CA (1) CA2670615C (cg-RX-API-DMAC7.html)
ES (1) ES2422597T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ577992A (cg-RX-API-DMAC7.html)
WO (1) WO2008067091A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903411B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9625453B2 (en) * 2006-11-28 2017-04-18 Pictor Limited Assay membrane and method of use thereof
CA2818483C (en) * 2010-11-17 2020-12-15 Aushon Biosystems Method of and system for printing in-well calibration features
WO2013074643A2 (en) 2011-11-14 2013-05-23 Aushon Biosystems, Inc. Systems and methods to enhance consistency of assay performance
JP2015522277A (ja) 2012-06-28 2015-08-06 カルドラ ヘルス リミテッドＣａｌｄｅｒａ Ｈｅａｌｔｈ Ｌｔｄ 前立腺癌の診断方法と診断用物質
US9427707B2 (en) 2012-08-10 2016-08-30 Jean I. Montagu Filtering blood
EP3022322A4 (en) 2013-07-17 2017-05-17 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
GB201314452D0 (en) * 2013-08-13 2013-09-25 Ostara Biomedical Ltd Embryo implantation
WO2015120382A1 (en) 2014-02-07 2015-08-13 The Johns Hopkins University Predicting response to epigenetic drug therapy
FR3019654B1 (fr) * 2014-04-04 2020-10-30 Bio Rad Innovations Controles pour la mise en oeuvre de procedes d'analyse multiplexe
US9903868B2 (en) 2014-05-16 2018-02-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for the detection and quantitation of biomarkers
US10222386B2 (en) 2014-09-19 2019-03-05 The Johns Hopkins University Biomarkers of congnitive dysfunction
GB201501302D0 (en) 2015-01-27 2015-03-11 Ostara Biomedical Ltd Embryo implantation
US11041865B2 (en) 2015-02-20 2021-06-22 The Johns Hopkins University Biomarkers of myocardial injury
GB201517523D0 (en) 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction
US10973679B2 (en) * 2016-02-12 2021-04-13 Adam Arreola STD detecting condom
EP3586136B1 (en) 2017-02-24 2023-11-08 Board Of Regents, The University Of Texas System Assay for detection of early stage pancreatic cancer
US11117128B2 (en) 2017-08-25 2021-09-14 Vanadis Diagnostics Ab Filtration device
WO2019067592A1 (en) 2017-09-27 2019-04-04 University Of Georgia Research Foundation TREATMENT AND DETECTION OF INFECTION AND DISEASE ASSOCIATED WITH DIFFERENT FUNGAL PATHOGENS
WO2019204784A1 (en) * 2018-04-19 2019-10-24 First Light Biosciences, Inc. Detection of targets
AU2020212016A1 (en) 2019-01-24 2021-08-05 University Of Georgia Research Foundation Treatment and detection of infection and disease associated with different fungal pathogens
WO2020264156A1 (en) 2019-06-25 2020-12-30 Musc Foundation For Research Development Asymmetric dimethylarginine (adma) as a marker for vascular pathologies
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array
CN111796101B (zh) * 2020-07-14 2022-08-26 汕头市中心医院 Notch3蛋白表达量检测剂联合cypa蛋白表达量检测剂在预测癌症治疗疗效的用途
CN116547537A (zh) 2020-07-29 2023-08-04 皮克托有限公司 SARS-CoV-2抗体免疫测定
WO2022025773A1 (en) * 2020-07-29 2022-02-03 Pictor Limited Immunoassay for sars-cov-2 antibodies
CN116134151A (zh) * 2020-08-07 2023-05-16 维塔生物科技公司 多重分析物检测
WO2022039604A1 (en) * 2020-08-21 2022-02-24 Pictor Limited Multiplex assay for johne's disease and pregnancy
WO2022072479A1 (en) 2020-09-29 2022-04-07 The Johns Hopkins University Integrated proteomic biomarkers for the detection of aggressive prostate cancer
WO2022119459A1 (en) * 2020-12-03 2022-06-09 Pictor Limited Device and method of analyte detection
WO2022193028A1 (en) * 2021-03-19 2022-09-22 Kenota Inc. Assay membrane test region localization
CN113070113B (zh) * 2021-06-03 2021-08-20 成都齐碳科技有限公司 芯片结构、成膜方法、纳米孔测序装置及应用
CN113791210B (zh) * 2021-09-17 2024-10-29 石家庄洹众生物科技有限公司 一种同时检测基质金属蛋白酶-8和白细胞介素-6的试剂条、装置及其应用
CN116519956A (zh) * 2023-04-19 2023-08-01 三诺生物传感股份有限公司 一种降钙素原校准品基质液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153013A1 (en) * 2002-11-07 2003-08-14 Ruo-Pan Huang Antibody-based protein array system

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417324B1 (en) * 2000-04-21 2002-07-09 Tripep Ab Synthetic peptides that bind to the hepatitis B virus core and e antigens
DE69836493T2 (de) * 1998-07-22 2007-09-06 Syntron Bioresearch, Inc., Carlsbad Vorrichtung zur bestimmung von mehreren analyten
US6942771B1 (en) * 1999-04-21 2005-09-13 Clinical Micro Sensors, Inc. Microfluidic systems in the electrochemical detection of target analytes
US6753143B2 (en) * 2000-05-01 2004-06-22 Clinical Micro Sensors, Inc. Target analyte detection using asymmetrical self-assembled monolayers
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
ATE458199T1 (de) * 2001-05-04 2010-03-15 Biosite Inc Diagnostische marker der akuten koronaren syndrome und ihre verwendungen
US7063979B2 (en) * 2001-06-13 2006-06-20 Grace Bio Labs., Inc. Interface between substrates having microarrays and microtiter plates
US20050153381A1 (en) * 2002-02-14 2005-07-14 Marusich Michael F. Immunocapture of mitochondrial protein complexes
JP4741249B2 (ja) * 2002-11-16 2011-08-03 シーメンス・ヘルスケア・ダイアグノスティックス・プロダクツ・ゲーエムベーハー 心血管疾患における生化学的マーカーの組合せとしてのｓＣＤ４０Ｌ，ＰＡＰＰ−Ａおよび胎盤増殖因子（ＰｌＧＦ）
US20040191810A1 (en) * 2002-12-17 2004-09-30 Affymetrix, Inc. Immersed microarrays in conical wells
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
CN100357738C (zh) 2004-03-26 2007-12-26 博奥生物有限公司 一种检测小分子化合物的方法
US20060024703A1 (en) * 2004-06-01 2006-02-02 The Regents Of The University Of Michigan Library on a slide and the use thereof
EP1782074A2 (en) * 2004-08-18 2007-05-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Biomarkers for osteoarthritis
EP1872293A4 (en) * 2005-03-28 2010-01-06 Bioseek Inc PROFILING BIOLOGICAL DATA FOR CARDIOVASCULAR DISEASES AND CARDIOVASCULAR INFLAMMATION
CA2606815C (en) 2005-05-02 2017-03-07 Anp Technologies, Inc. Polymer conjugate enhanced bioassays
RU2442171C2 (ru) 2006-09-21 2012-02-10 Промитьюс Лабораториз Инк. Чипы на основе антител для определения множественных трансдукторов сигналов в редких циркулирующих клетках
US9625453B2 (en) * 2006-11-28 2017-04-18 Pictor Limited Assay membrane and method of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153013A1 (en) * 2002-11-07 2003-08-14 Ruo-Pan Huang Antibody-based protein array system

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUANG et al., SIMULTANEOUS DETECTION OF MULTIPLE CYTOKINES FROM CONDITIONED MEDIA AND PATIENT'S SERA BY AN ANTIBODY-BASED PROTEIN ARRAY SYSTEM, ANALYTICAL BIOCHEMISTRY, 31 May 2001, Vol 294, Pages 55-62 *
S. KASTENBAUER et al., PATTERNS OF PROTEIN EXPRESSION IN INFECTIOUS MENINGITIS: A CEREBROSPINAL FLUID PROTEIN ARRAY ANALYSIS, Journal of Neuroimmunology, 01 July 2005, Vol. 164, No. 1-2, Pages 134-139 *
Y. LI et al., PROTEIN ARRAY METHOD FOR ASSESSING IN VITRO BIOMATERIAL-INDUCED CYTOKINE EXPRESSION, BIOMATERIALS, 01 April 2005, Vol. 26, No. 10, Pages 1081-1085 *

Also Published As

Publication number Publication date
NZ577992A (en) 2012-09-28
ES2422597T3 (es) 2013-09-12
US9625453B2 (en) 2017-04-18
US10948486B2 (en) 2021-03-16
US20100093557A1 (en) 2010-04-15
JP5240945B2 (ja) 2013-07-17
WO2008067091A2 (en) 2008-06-05
JP2010511177A (ja) 2010-04-08
WO2008067091A3 (en) 2008-08-28
CA2670615A1 (en) 2008-06-05
ZA200903411B (en) 2010-03-31
EP2092333A4 (en) 2010-01-20
EP2092333A2 (en) 2009-08-26
AU2007325465A1 (en) 2008-06-05
EP2092333B1 (en) 2013-05-01
US20180067109A1 (en) 2018-03-08
CA2670615C (en) 2018-05-01

Similar Documents

Publication Publication Date Title
AU2007325465B2 (en) Assay membrane and method of use thereof
JP2007530925A (ja) 低分子化合物を検出するための方法およびバイオチップ
CN1700009A (zh) 用单一捕获剂定量检测特异性分析物的方法及其试剂盒
JP2024057619A (ja) ウイルス感染と細菌感染を区別するためのマルチプレックスラテラルフローアッセイ
CN103823058B (zh) 血清中抗原类蛋白的化学发光蛋白芯片方法和试剂盒
CN110366677A (zh) 为数字测定使用横向照明的光学成像系统
JP2024061719A (ja) ウイルス感染と細菌感染を区別するためのマルチプレックスラテラルフローアッセイ
KR102047517B1 (ko) 막 기반 다중튜브를 포함하는 생체 물질 분석 장치
CN109781972B (zh) 一种免疫定量检测方法和应用
US12235269B2 (en) Immunoassay for SARS-CoV-2 antibodies
US20220034904A1 (en) IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
US20210318311A1 (en) Simultaneous detection of humoral and inflammatory biomarkers
JP2014228385A (ja) 免疫試験方法および免疫試験キット
Gannot et al. Layered peptide arrays: high-throughput antibody screening of clinical samples
CN212748940U (zh) 多种抗原抗体检测一体式反应管
JP5714791B2 (ja) 非特異反応抑制剤
JP2007147494A (ja) 同時物質測定方法およびそれに使用する測定用支持体
CN109313190A (zh) 通过流体样品再利用而使流体样品多重化的设备、方法和试剂盒
Matson Lateral Flow Microarray-Based ELISA for Cytokines
CN120121848B (zh) 一种用于检测难溶性蛋白的胶体金试剂盒及检测方法
WO2005119258A1 (ja) 複数物質同時測定方法およびそれに使用する測定用デバイス
CN119522367A (zh) 免疫学测定方法、非特异反应抑制方法、免疫学测定试剂、免疫学测定试剂盒、组合物、非特异反应抑制剂和用途
WO2022039604A1 (en) Multiplex assay for johne's disease and pregnancy
WO2022025773A1 (en) Immunoassay for sars-cov-2 antibodies
Urbanowska Development of a protein microarray platform for the multiplex analysis of biomarkers associated with Rheumatoid arthritis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired